Costa Rica's Medtech Shift: Why Engineering Is the New Manufacturing

Jan de Vries · 2026-11-06

Costa Rica isn't just assembling medical devices anymore. It's designing them. That's a big shift, and it's changing how the country attracts medtech investment. For years, Costa Rica was known as a low-cost manufacturing hub for medical devices. Companies like Medtronic and Baxter set up shop to take advantage of skilled labor and proximity to the U.S. But now, the country is betting on a different future—one where it engineers the products, not just builds them. ### From Assembly Lines to R&D Labs The transition didn't happen overnight. It's the result of deliberate investments in education, infrastructure, and supplier networks. Costa Rica's free trade zones (FTZs) have played a key role, offering tax incentives and a supportive regulatory environment. But the real catalyst? A growing pool of engineers. Universities like the Instituto Tecnológico de Costa Rica (TEC) are churning out more engineering graduates each year. And the government has been working with industry to align curricula with medtech needs. The result: a workforce that can handle everything from product design to quality assurance. > "We're not just making devices; we're making them smarter," says one industry insider. "The engineering talent here is on par with anywhere in the world." ### The Supplier Ecosystem: The Hidden Engine You can't engineer devices without the right parts. That's why Costa Rica has been nurturing a local supplier ecosystem. Instead of importing every component, companies are sourcing more from local firms. This not only reduces lead times but also fosters innovation. - **Local sourcing:** More than 50 local suppliers now serve the medtech sector, up from just a handful a decade ago. - **Digital capabilities:** Companies are investing in automation, data analytics, and IoT to streamline production and improve quality. - **Collaboration:** Industry clusters are forming, where manufacturers, suppliers, and universities share knowledge and resources. This ecosystem approach is paying off. Costa Rica is now the second-largest exporter of medical devices to the U.S., behind only Mexico. But the goal is to move up the value chain—from simple devices to complex, high-tech equipment. ### The Challenges Ahead Of course, there are hurdles. Infrastructure gaps, especially in transportation and logistics, can slow things down. And competition from other low-cost countries is fierce. But Costa Rica's focus on engineering and innovation gives it an edge. The country is also betting on digital health. With a growing number of startups in telemedicine and health tech, there's potential to integrate software with hardware. That could open new markets and attract even more investment. ### What This Means for Medtech Investors If you're in medtech, Costa Rica is worth a closer look. The country offers a unique combination of cost efficiency and engineering talent. And with the government's commitment to innovation, the momentum is only building. But don't just take my word for it. Talk to companies already there. Visit the free trade zones. See the labs for yourself. You might be surprised by what you find. Costa Rica's medtech bet is a bold one. But if it pays off, it could redefine the country's role in the global medtech supply chain—and set an example for others to follow.